Analytical methods

Counterions and peptide salt forms

Almost every synthetic peptide you handle is a salt, not a free base. The counterion is a substantial fraction of what you weigh, it varies between batches, and in cell-based work it is not chemically inert.

The short version. Solid-phase synthesis cleaves with trifluoroacetic acid and reverse-phase purification runs in TFA buffer, so the peptide leaves the process as a TFA salt. TFA pairs with every basic site — arginine, lysine, histidine and the N-terminal amine — so the more basic the sequence, the more of the vial is counterion.

Published figures put TFA at roughly 10–30% of gross mass for typical peptides, higher for polybasic sequences. Acetate salts, produced by ion exchange, generally carry less. A certificate that does not name the counterion has left out a term you need.

The process

Where the counterion comes from

Two stages put TFA on the peptide. Cleavage from the resin and removal of side-chain protecting groups is done with concentrated trifluoroacetic acid. Then reverse-phase HPLC purification runs with TFA as the mobile-phase ion-pairing additive, because it improves peak shape and resolution.

Both leave TFA behind as an ion pair with the peptide's protonated basic sites. Lyophilisation removes the water and the volatile organics, but the counterion is ionically bound and stays.

Counterion load scales with basic sites

Count the arginine, lysine and histidine residues in the sequence and add one for the free N-terminal amine. That approximates the number of sites available for ion pairing, and it predicts roughly where in the published range a given peptide will sit.

Sequence character	Typical consequence
Few basic residues	Low TFA load, net peptide content toward the upper end of the range
Arg- or Lys-rich	High TFA load; net content can fall substantially
Net acidic sequence	Fewer protonated sites; often the least counterion of all
Free N-terminus	One additional site; an acetylated N-terminus removes it

BPC-157 illustrates the low end. Its sequence — Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val — has one lysine, no arginine and no histidine, against one glutamate and two aspartates. A single basic residue plus the N-terminus means comparatively little TFA and correspondingly high net peptide content. A lysine-rich sequence of the same length behaves very differently.

The part that gets skipped

Why TFA is not inert

TFA is not a passive makeweight. It has effects that matter in specific kinds of work.

Cytotoxicity. At sufficient concentration TFA reduces cell viability on its own. In an assay where viability is the readout, residual counterion can produce an apparent effect that belongs to the salt rather than the peptide — and it scales with the amount of material added, so it looks dose-dependent.
Infrared spectroscopy. The TFA carbonyl absorbs around 1670–1680 cm⁻¹, which overlaps the amide I band used for secondary-structure determination by FTIR. Structural work on a TFA salt needs the counterion removed or accounted for.
Circular dichroism. TFA absorbs in the far-UV region where CD spectra are recorded, raising the noise floor and limiting how far down the useful range extends.

If your work involves cell viability, secondary structure or far-UV spectroscopy, the counterion is an experimental variable rather than a bookkeeping detail.

And it differs between suppliers, and between batches from the same supplier. It belongs in the methods section — which means it needs to be on the certificate.

Comparison

Salt forms and how they compare

Form	Origin	Notes
TFA	Default from SPPS cleavage and RP-HPLC purification	Highest counterion mass fraction; the cytotoxicity and spectroscopy issues above
Acetate	Ion exchange, or lyophilisation from dilute acetic acid	Higher net peptide content; the form used for most peptide APIs
Hydrochloride	Ion exchange from dilute HCl	Low counterion mass; chloride interferes with some analyses
Free base	Rare for basic peptides	Often poorly soluble and less stable; seldom practical

Exchange is a real process with a real cost and a real yield loss, which is why research-grade material is usually supplied as the TFA salt. That is a reasonable default. What is not reasonable is failing to say which form was supplied, because the two cannot be compared on net content without it.

Method

How counterion content is measured

Ion chromatography. The standard approach — separates and quantifies the trifluoroacetate anion directly.
Fluorine-19 NMR. Elegant for TFA specifically, because trifluoroacetate is usually the only fluorinated species present. That makes the signal unambiguous and quantifiable against an internal standard, with no separation step.
Elemental analysis. Fluorine content by combustion, converted to TFA. Less common.

Any of these is acceptable. As with content determination generally, what matters is that the certificate names the method rather than presenting a bare percentage.

Field guide

What a certificate should carry

Four fields, and most certificates in this market carry none of them:

The counterion identity — TFA, acetate or hydrochloride.
Its mass percentage.
The method used to determine it.
Residual water by Karl Fischer, so the mass balance closes.

The reconciliation

With those alongside net peptide content, the numbers reconcile: peptide plus counterion plus water plus residual salts should approximate the gross weight. If they do not sum sensibly, one of the figures is wrong or estimated.

That reconciliation is the most useful single check you can run on a certificate, and it is only possible when the counterion is disclosed. The arithmetic is worked through in how to read a certificate of analysis.

Common questions

Why are peptides supplied as TFA salts rather than something more benign?

Because TFA is what the manufacturing process leaves behind. It is used for cleavage from the resin and as the ion-pairing additive in reverse-phase purification, where it genuinely improves peak shape and resolution. Converting to another salt form is an extra ion-exchange step with cost and yield loss attached, so it is usually reserved for material where the counterion matters.

Does the counterion change the peptide itself?

No. The peptide's covalent structure is unchanged — mass spectrometry of the peptide ion gives the same result either way. What changes is how much of the vial's mass is peptide, and how the material behaves in assays sensitive to the counterion.

Can I compare net peptide content between two suppliers?

Only if both state the salt form. An acetate salt will generally show higher net content than the same sequence as a TFA salt, purely because acetate contributes less mass per ion pair. Comparing the two figures without knowing the forms compares the salts rather than the suppliers.

How do I know if TFA is affecting my results?

The diagnostic is a vehicle control matched for counterion — sodium trifluoroacetate at the concentration your peptide addition delivers. If the control shows an effect, the counterion is contributing. This is standard practice in careful cell work and is rarely done in less careful work, which is one reason results in this area can be difficult to reproduce.

References

Sources

Standard references on solid-phase peptide synthesis and reverse-phase purification, for TFA as cleavage reagent and ion-pairing additive.
Manufacturer technical documentation on peptide salt forms, counterion exchange and net peptide content, including AmbioPharm's published guidance.
Literature on trifluoroacetate effects in cell culture, and on TFA interference in FTIR amide I and far-UV circular dichroism measurements.

What this page is

An analytical-chemistry reference for interpreting certificates of analysis. It is not medical advice, not a usage guide, and describes no application in humans or animals. Everything Ethereal Peptides supplies is a laboratory research material and is not for human or veterinary use.